These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1346 related articles for article (PubMed ID: 26111015)

  • 1. N-trimethyl chitosan chloride-coated PLGA nanoparticles overcoming multiple barriers to oral insulin absorption.
    Sheng J; Han L; Qin J; Ru G; Li R; Wu L; Cui D; Yang P; He Y; Wang J
    ACS Appl Mater Interfaces; 2015 Jul; 7(28):15430-41. PubMed ID: 26111015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficient mucus permeation and tight junction opening by dissociable "mucus-inert" agent coated trimethyl chitosan nanoparticles for oral insulin delivery.
    Liu M; Zhang J; Zhu X; Shan W; Li L; Zhong J; Zhang Z; Huang Y
    J Control Release; 2016 Jan; 222():67-77. PubMed ID: 26686663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Enhancement of gastrointestinal absorption of chitosan-coated insulin-loaded poly (lactic-co-glycolic acid) nanoparticles].
    Pan Y; Li YJ; Gao P; Ding PT; Xu H; Zheng JM
    Yao Xue Xue Bao; 2003 Jun; 38(6):467-70. PubMed ID: 14513811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folate-decorated PLGA nanoparticles as a rationally designed vehicle for the oral delivery of insulin.
    Jain S; Rathi VV; Jain AK; Das M; Godugu C
    Nanomedicine (Lond); 2012 Sep; 7(9):1311-37. PubMed ID: 22583576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancing insulin oral absorption by using mucoadhesive nanoparticles loaded with LMWP-linked insulin conjugates.
    Sheng J; He H; Han L; Qin J; Chen S; Ru G; Li R; Yang P; Wang J; Yang VC
    J Control Release; 2016 Jul; 233():181-90. PubMed ID: 27178809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro uptake evaluation in Caco-2 cells and in vivo results in diabetic rats of insulin-loaded PLGA nanoparticles.
    Reix N; Parat A; Seyfritz E; Van der Werf R; Epure V; Ebel N; Danicher L; Marchioni E; Jeandidier N; Pinget M; Frère Y; Sigrist S
    Int J Pharm; 2012 Nov; 437(1-2):213-20. PubMed ID: 22940208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intranasal delivery of Huperzine A to the brain using lactoferrin-conjugated N-trimethylated chitosan surface-modified PLGA nanoparticles for treatment of Alzheimer's disease.
    Meng Q; Wang A; Hua H; Jiang Y; Wang Y; Mu H; Wu Z; Sun K
    Int J Nanomedicine; 2018; 13():705-718. PubMed ID: 29440896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation and in vitro evaluation of thienorphine-loaded PLGA nanoparticles.
    Yang Y; Xie XY; Mei XG
    Drug Deliv; 2016; 23(3):787-93. PubMed ID: 24870204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel PLGA-based nanoparticles for the oral delivery of insulin.
    Malathi S; Nandhakumar P; Pandiyan V; Webster TJ; Balasubramanian S
    Int J Nanomedicine; 2015; 10():2207-18. PubMed ID: 25848248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficient Peroral Delivery of Insulin via Vitamin B12 Modified Trimethyl Chitosan Nanoparticles.
    Ke Z; Guo H; Zhu X; Jin Y; Huang Y
    J Pharm Pharm Sci; 2015; 18(2):155-70. PubMed ID: 26158281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation and characterization of insulin-loaded bioadhesive PLGA nanoparticles for oral administration.
    Zhang X; Sun M; Zheng A; Cao D; Bi Y; Sun J
    Eur J Pharm Sci; 2012 Apr; 45(5):632-8. PubMed ID: 22248882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral insulin delivery, the challenge to increase insulin bioavailability: Influence of surface charge in nanoparticle system.
    Czuba E; Diop M; Mura C; Schaschkow A; Langlois A; Bietiger W; Neidl R; Virciglio A; Auberval N; Julien-David D; Maillard E; Frere Y; Marchioni E; Pinget M; Sigrist S
    Int J Pharm; 2018 May; 542(1-2):47-55. PubMed ID: 29501738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of chitosan-coated poly(lactic-co-glycolic acid) nanoparticles for improving oral absorption of 7-ethyl-10-hydroxycamptothecin.
    Guo M; Rong WT; Hou J; Wang DF; Lu Y; Wang Y; Yu SQ; Xu Q
    Nanotechnology; 2013 Jun; 24(24):245101. PubMed ID: 23702815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enteric-coated capsules filled with mono-disperse micro-particles containing PLGA-lipid-PEG nanoparticles for oral delivery of insulin.
    Yu F; Li Y; Liu CS; Chen Q; Wang GH; Guo W; Wu XE; Li DH; Wu WD; Chen XD
    Int J Pharm; 2015 Apr; 484(1-2):181-91. PubMed ID: 25724135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controlled synthesis of in-situ gold nanoparticles onto chitosan functionalized PLGA nanoparticles for oral insulin delivery.
    Asal HA; Shoueir KR; El-Hagrasy MA; Toson EA
    Int J Biol Macromol; 2022 Jun; 209(Pt B):2188-2196. PubMed ID: 35504421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Goblet cell-targeting nanoparticles for oral insulin delivery and the influence of mucus on insulin transport.
    Jin Y; Song Y; Zhu X; Zhou D; Chen C; Zhang Z; Huang Y
    Biomaterials; 2012 Feb; 33(5):1573-82. PubMed ID: 22093292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nasal vaccination with N-trimethyl chitosan and PLGA based nanoparticles: nanoparticle characteristics determine quality and strength of the antibody response in mice against the encapsulated antigen.
    Slütter B; Bal S; Keijzer C; Mallants R; Hagenaars N; Que I; Kaijzel E; van Eden W; Augustijns P; Löwik C; Bouwstra J; Broere F; Jiskoot W
    Vaccine; 2010 Aug; 28(38):6282-91. PubMed ID: 20638455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HP55-coated capsule containing PLGA/RS nanoparticles for oral delivery of insulin.
    Wu ZM; Zhou L; Guo XD; Jiang W; Ling L; Qian Y; Luo KQ; Zhang LJ
    Int J Pharm; 2012 Apr; 425(1-2):1-8. PubMed ID: 22248666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modified nanoparticles with cell-penetrating peptide and amphipathic chitosan derivative for enhanced oral colon absorption of insulin: preparation and evaluation.
    Guo F; Zhang M; Gao Y; Zhu S; Chen S; Liu W; Zhong H; Liu J
    Drug Deliv; 2016 Jul; 23(6):2003-14. PubMed ID: 26181840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lyophilized insulin nanoparticles prepared from quaternized N-aryl derivatives of chitosan as a new strategy for oral delivery of insulin: in vitro, ex vivo and in vivo characterizations.
    Mahjub R; Radmehr M; Dorkoosh FA; Ostad SN; Rafiee-Tehrani M
    Drug Dev Ind Pharm; 2014 Dec; 40(12):1645-59. PubMed ID: 24093431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 68.